PRD Therapeutics Announces Initiation of First-in-Human Study for PRD001
This FIH Phase 1 study is designed to evaluate the [...]
Martin Stumpe Appointed as Chief Technology and AI Officer at Danaher
Danaher Corporation (NYSE: DHR), a leading global life sciences and [...]
Greg Milosevich Appointed EVP, Life Sciences at Danaher
Greg Milosevich joined Danaher in 2010, through the acquisition of [...]
Drug-Free Nasal Spray LUCA V-Defense Creates a Protective Shield Against Viruses and Allergies
Unlike traditional nasal sprays that rely on steroids or antihistamines, [...]
Avio Health Launches World’s First Functional Medicine LLM for Emagene Life, Transforming Personalized Healthcare
This breakthrough follows 18 months of intensive research and development, [...]
Orphalan Partners with MAP International and the Wilson Disease Association to Provide Life-Changing Medicine to Underserved Communities
Through this partnership, Orphalan will donate a supply of Cuvrior® [...]
Initiation of Commercialization of ProNephro AKI (NGAL) for Diagnostic Use in the US
This purchase order is to service US hospitals through BioPorto’s [...]
Major Investment from Genome Canada to Help Advance ClarityDX Prostate Adoption Across Canada
The funding to propel widespread adoption and integration of innovative [...]
Wysa Partners with RxCap to Advance Medication Adherence
Wysa, a global leader in AI-driven behavioral health support announced [...]
ACIP Recommends Use of Merck’s ENFLONSIA for Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season
ENFLONSIA is the first and only RSV preventive option for [...]